Hepatic lesions detected in patients who previously suffered from breast cancer with either HBV infection or a resolved HBV infection, regardless of AFP levels, may receive liver biopsy to avoid unnecessary and inappropriate treatments for metastasis. Here, AFP is linked to breast carcinoma.